設為首頁
On March 30, 2016, the United States medical implant maker Renovis Surgical Technologies, the company announced that the company's 3 d printing TeseraSC - porous titanium cervical intervertebral fusion system, the U.S. food and drug administration (FDA) in 510 (K) market access permission. Learned, TeseraSC porous titanium is a kind of independent system between cervical fusion, it has a fixed design includes three screws and a locking plate, in order to prevent the screw loose. The implant is used for two kinds of lordosis Angle, and height and size can be changed according to the situation, to be used for specific repairing intervertebral height, and through the use of advanced instruments designed to reduce the operation steps.
It is understood that all Tesera implants are created 3 d printing, in addition, the company currently has a is applying for patent design, can produce highly porous surface structure, so that we can make further implant bone in growth, so as to maximize the strength, stability, and stability.
It is also a Renovis Surgical company fourth batch of approved by the FDA has Tesera porous titanium metal structure products. The other three products including in September, 2013, approved by the independent anterior spinal fusion Tesera SA system; In April 2014, approved by Tesera adult acetabulum reconstruction system; And in February 2015, approved by Tesera between posterior lumbar series and so on.
